Technical Analysis for REPL - Replimune Group, Inc.

Grade Last Price % Change Price Change
C 11.69 -4.10% -0.50
REPL closed down 4.1 percent on Wednesday, November 13, 2024, on 58 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Support Bullish -4.10%
Hammer Candlestick Bullish -4.10%
Slingshot Bullish Bullish Swing Setup -4.10%
Bollinger Band Squeeze Range Contraction -4.10%
BB Squeeze Started Range Contraction -4.10%

   Recent Intraday Alerts

Alert Time
Down 3% about 8 hours ago
Down 2 % about 10 hours ago
20 DMA Support about 11 hours ago
Down 1% about 11 hours ago
60 Minute Opening Range Breakdown about 11 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Replimune Group, Inc. is a clinical-stage biotechnology company. The Company is engaged in the field of oncolytic immunotherapy to treat the cancer patients. The Company applies its Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The Company is focused on developing a pipeline of oncolytic immunotherapy product candidates to provide clinical benefits to cancer patients. Its product candidates include RP, RP2, and RP3. The Company is focused on Phase 1/2 clinical trial with its lead product candidate, RP1, in approximately 150 patients with a range of solid tumors.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Solid Tumors Immune System Immunotherapy Cancer Treatment Virotherapy Immunotherapy Products Oncolytic Virus Experimental Cancer Treatments Transgene Sa Akseli Hemminki Rp1

Is REPL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.97
52 Week Low 4.92
Average Volume 662,348
200-Day Moving Average 9.00
50-Day Moving Average 11.44
20-Day Moving Average 11.99
10-Day Moving Average 12.14
Average True Range 0.70
RSI (14) 47.92
ADX 16.46
+DI 16.47
-DI 20.85
Chandelier Exit (Long, 3 ATRs) 10.87
Chandelier Exit (Short, 3 ATRs) 12.04
Upper Bollinger Bands 12.69
Lower Bollinger Band 11.28
Percent B (%b) 0.29
BandWidth 11.71
MACD Line 0.23
MACD Signal Line 0.27
MACD Histogram -0.0399
Fundamentals Value
Market Cap 717.62 Million
Num Shares 61.4 Million
EPS -3.16
Price-to-Earnings (P/E) Ratio -3.70
Price-to-Sales 0.00
Price-to-Book 1.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.36
Resistance 3 (R3) 13.52 13.12 13.08
Resistance 2 (R2) 13.12 12.70 13.04 12.98
Resistance 1 (R1) 12.41 12.44 12.21 12.25 12.89
Pivot Point 12.01 12.01 11.92 11.93 12.01
Support 1 (S1) 11.30 11.59 11.10 11.14 10.49
Support 2 (S2) 10.90 11.33 10.82 10.40
Support 3 (S3) 10.19 10.90 10.30
Support 4 (S4) 10.03